Complete remission after patisiran treatment in a patient with nephrotic syndrome secondary to hereditary transthyretin amyloidosis (ATTR)

被引：0
|
作者：
Vila, Axel [1 ]
Moktefi, Anissa [2 ,3 ]
Damy, Thibaud [4 ,5 ]
Plante-Bordeneuve, Violaine [6 ]
Remy, Philippe [1 ]
Colombat, Magali [7 ]
Audard, Vincent [1 ,2 ]
Sakhi, Hamza [1 ,2 ]
机构：
[1] Hop Univ Henri Mondor, Assistance Publ Hop Paris APHP, Ctr Reference Malad Rare Syndrome Nephrot Idiopath, Serv Nephrol & Transplantat, Creteil, France
[2] Univ Paris Est Creteil, Inst Mondor Rech Biomed IMRB, Inst Natl Sante & Rech Med, INSERM U955, Creteil, France
[3] Hop Univ Henri Mondor, Serv Anatomopathol, Creteil, France
[4] Univ Paris Est Creteil, Equipe CEpiA Clin Epidemiol & Aging, INSERM U955, IMRB, Creteil, France
[5] Hop Univ Henri Mondor, AP HP, Serv Cardiol, GRC Amyloid Res Inst,Ctr Reference Natl Amyloses C, Creteil, France
[6] Hop Univ Henri Mondor, AP HP, GRC Amyloid Res Inst, Serv Neurol, Creteil, France
[7] Ctr Hosp Univ Toulouse, Serv Anatomopathol, Toulouse, France
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2025年
关键词：
Hereditary Transthyretin Amyloidosis; Nephrotic Syndrome; Patisiran; Tafamidis;
D O I：
10.1080/13506129.2025.2472819
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Indirect comparison of patisiran and tafamidis for treatment of hereditary transthyretin- mediated (hATTR) amyloidosis with polyneuropathy
    Coelho, Teresa
    Polydefkis, Michael
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Plante-Bordeneuve, Violaine
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 254 - 255
  • [22] Recurrence and spontaneous remission of nephrotic syndrome in renal secondary amyloidosis
    Costero, O
    Riñón, C
    Gil, F
    Díaz, C
    Hevia, C
    Picazo, ML
    Martínez-Ara, J
    NEFROLOGIA, 2002, 22 (05): : 482 - 485
  • [23] NFL AS A POSSIBLE BIOMARKER OF TREATMENT RESPONSE IN HEREDITARY ATTR AMYLOIDOSIS: DATA FROM THE PATISIRAN APOLLO OLE STUDY
    Sekijima, Y.
    Polydefkis, M.
    Ticau, S.
    Erbe, D.
    McManus, A.
    Aldinc, E.
    Adams, D.
    Reilly, M. M.
    Vaishnaw, A.
    Nioi, P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S12 - S13
  • [24] Regression of amyloid load in subcutaneous fat tissue of hereditary transthyretin amyloidosis patients during treatment with patisiran
    Tingen, Hendrea
    Bijzet, Johan
    Berends, Milou
    te Bogt, Daniek
    Tubben, Alwin
    van der Meer, Peter
    Slart, Riemer
    Muntinghe, Friso L. H.
    Houwerzijl, Ewout J.
    van der Zwaag, Paul A.
    Hazenberg, Bouke P. C.
    Nienhuis, Hans
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S191 - S192
  • [25] Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis
    Shunsuke Yamada
    Akihiro Tsuchimoto
    Yoshiki Kaizu
    Masatomo Taniguchi
    Kosuke Masutani
    Hiroshi Tsukamoto
    Hiroaki Ooboshi
    Kazuhiko Tsuruya
    Takanari Kitazono
    CEN Case Reports, 2014, 3 (2) : 237 - 243
  • [26] Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis
    Yamada, Shunsuke
    Tsuchimoto, Akihiro
    Kaizu, Yoshiki
    Taniguchi, Masatomo
    Masutani, Kosuke
    Tsukamoto, Hiroshi
    Ooboshi, Hiroaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    CEN CASE REPORTS, 2014, 3 (02): : 237 - 243
  • [27] A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis (vol 9, pg 301, 2020)
    Urits, Ivan
    Swanson, Daniel
    Swett, Michael C.
    Patel, Anjana
    Berardino, Kevin
    Amgalan, Ariunzaya
    Berger, Amnon A.
    Kassem, Hisham
    Kaye, Alan D.
    Viswanath, Omar
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 407 - 407
  • [28] The patient with over 100 relapses of minimal change nephrotic syndrome:: prolonged complete remission after chlorambucil treatment
    Carreño, A
    Morales, E
    Domínguez-Gil, B
    Herrero, JC
    Ortiz, M
    González, E
    Praga, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (06) : 922 - 923
  • [29] Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy
    Gentile, Luca
    Mazzeo, Anna
    Briani, Chiara
    Casagrande, Silvia
    De Luca, Marcella
    Fabrizi, Gian Maria
    Gagliardi, Christian
    Gemelli, Chiara
    Forcina, Francesca
    Grandis, Marina
    Guglielmino, Valeria
    Iabichella, Giacomo
    Leonardi, Luca
    Lozza, Alessandro
    Manganelli, Fiore
    Mussinelli, Roberta
    My, Filomena
    Occhipinti, Giuseppe
    Fenu, Silvia
    Russo, Massimo
    Romano, Angela
    Salvalaggio, Alessandro
    Tagliapietra, Matteo
    Tozza, Stefano
    Palladini, Giovanni
    Obici, Laura
    Luigetti, Marco
    NEUROLOGICAL SCIENCES, 2024, 45 (09) : 4563 - 4571
  • [30] COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY
    Brown, D.
    Vera-Llonch, M.
    Shaff, M.
    Rolli, A.
    Vega, M.
    Blum, M.
    Nestler-Parr, S.
    Jiresch, M.
    Weycker, D.
    VALUE IN HEALTH, 2020, 23 : S606 - S607
12345